Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


06.06.2022

8 Anticancer Res
1 BMC Cancer
1 Br J Oral Maxillofac Surg
2 Clin Cancer Res
1 Clin Nucl Med
1 Dis Esophagus
3 Head Neck
1 Hum Pathol
1 Laryngoscope
7 Oral Oncol
2 PLoS One
1 Surgery


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Anticancer Res

  1. DAVAKIS S, Kapelouzou A, Liakakos T, Mpoura M, et al
    The Role of Toll-like Receptors in Esophageal Cancer.
    Anticancer Res. 2022;42:2813-2818.
    PubMed         Abstract available

  2. TAKAHASHI K, Nishikawa K, Tanishima Y, Ishikawa Y, et al
    Risk Stratification of Postoperative Pneumonia in Patients Undergoing Subtotal Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2022;42:3023-3028.
    PubMed         Abstract available

  3. BOOKA E, Kikuchi H, Haneda R, Soneda W, et al
    Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal Cancer.
    Anticancer Res. 2022;42:2977-2987.
    PubMed         Abstract available

  4. RADES D, Warwas B, Cremers F, Gerull K, et al
    The First Prognostic Tool to Estimate the Risk of Late Grade >/=3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer.
    Anticancer Res. 2022;42:3035-3039.
    PubMed         Abstract available

  5. ITO K, Ishida H, Fujishima F, Nakamura Y, et al
    Murine Double Minute 2 Antagonist Nutlin-3 Enhanced Chemosensitivity in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:2875-2882.
    PubMed         Abstract available

  6. MATSUKI T, Fushimi C, Miyamoto S, Takahashi H, et al
    Preoperative S-1 Therapy for Head and Neck Carcinoma During the Waiting Period Before Surgery.
    Anticancer Res. 2022;42:3177-3183.
    PubMed         Abstract available

  7. MUSIO D, DE Vincentiis M, D'Urso P, Musacchio A, et al
    Hearing Loss After Cisplatin-based Chemoradiotherapy for Locally Advanced Head and Neck Cancer: A Prospective Single-institution Study.
    Anticancer Res. 2022;42:3003-3009.
    PubMed         Abstract available

  8. ENDO M, Nishioka T, Numazaki K, Hasegawa H, et al
    Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells.
    Anticancer Res. 2022;42:2931-2937.
    PubMed         Abstract available


    BMC Cancer

  9. ZOU X, Zhou Q, Nie Y, Gou J, et al
    Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.
    BMC Cancer. 2022;22:595.
    PubMed         Abstract available


    Br J Oral Maxillofac Surg

  10. SUBASH A, Bylapudi B, Thakur S, Rao VUS, et al
    Robotic Neck Dissection in Head and Neck Cancer: A safe perception or deception?
    Br J Oral Maxillofac Surg. 2022 Apr 22. pii: S0266-4356(22)00128.
    PubMed        


    Clin Cancer Res

  11. LEDDON JL, Gulati S, Haque S, Allen C, et al
    Phase 2 trial of adjuvant nivolumab following salvage resection in patients with recurrent squamous cell carcinoma of the head and neck.
    Clin Cancer Res. 2022 Jun 2. pii: 699312. doi: 10.1158/1078-0432.CCR-21-4554.
    PubMed         Abstract available

  12. WANG W, Lozar T, Golfinos AE, Lee D, et al
    Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade.
    Clin Cancer Res. 2022 May 27:OF1-OF16. doi: 10.1158/1078-0432.CCR-21-3039.
    PubMed         Abstract available


    Clin Nucl Med

  13. MAMALIGA T, Liu Y
    Hypermetabolic Esophagitis Dessicans Superficialis Mimicking Esophageal Cancer on FDG PET/CT.
    Clin Nucl Med. 2022 May 27. pii: 00003072-990000000-00161.
    PubMed         Abstract available


    Dis Esophagus

  14. YANG Y, Tan L, Hu J, Li Y, et al
    Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China.
    Dis Esophagus. 2022 Jun 2. pii: 6596998. doi: 10.1093.
    PubMed         Abstract available


    Head Neck

  15. KOKSAL M, Saur L, Scafa D, Sarria G, et al
    Late toxicity-related symptoms and fraction dose affect decision regret among patients receiving adjuvant radiotherapy for head and neck cancer.
    Head Neck. 2022 May 30. doi: 10.1002/hed.27103.
    PubMed         Abstract available

  16. TSANG RK, Chan WCP, Holsinger FC, Chung JCK, et al
    Long-term results of robotic-assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Jun 1. doi: 10.1002/hed.27115.
    PubMed         Abstract available

  17. CHARGI N, Breik O, Forouzanfar T, Martin T, et al
    Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27113.
    PubMed         Abstract available


    Hum Pathol

  18. GAO Y, Wang P, Lu J, Pan B, et al
    Diagnostic significance of parafibromin expression in parathyroid carcinoma.
    Hum Pathol. 2022 May 30. pii: S0046-8177(22)00141.
    PubMed         Abstract available


    Laryngoscope

  19. SATHE P, Thiagarajan S
    Can Dental Care Alone Influence Treatment Outcomes in Head and Neck Cancer Patients?
    Laryngoscope. 2022 May 28. doi: 10.1002/lary.30228.
    PubMed        


    Oral Oncol

  20. JAYARAMAN S, Pazhani J, PriyaVeeraraghavan V, Raj AT, et al
    PCNA and Ki67: Prognostic proliferation markers for oral cancer.
    Oral Oncol. 2022;130:105943.
    PubMed        

  21. BALACHANDER K, Paramasivam A
    Selective autophagy as a potential therapeutic target for oral cancer.
    Oral Oncol. 2022;130:105934.
    PubMed        

  22. VARGHESE BT, Shivanesan P
    Anatomical distortion of the right recurrent laryngeal nerve in level 7 neck dissection.
    Oral Oncol. 2022;130:105929.
    PubMed        

  23. WARNER L, O'Hara JT, Lin DJ, Oozeer N, et al
    Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes.
    Oral Oncol. 2022;130:105909.
    PubMed         Abstract available

  24. PATIL VM, Kolkur M, Kumar Chinthala S, Waratkar G, et al
    Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.
    Oral Oncol. 2022;130:105908.
    PubMed        

  25. UEDA Y, Okano S, Enokida T, Fujisawa T, et al
    Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study.
    Oral Oncol. 2022;130:105932.
    PubMed         Abstract available

  26. SMILINE GIRIJA AS
    Natural "epidrugs" and the need of basket trials in the treatment of oral cancer in India.
    Oral Oncol. 2022;130:105931.
    PubMed        


    PLoS One

  27. BLATT S, Kruger M, Rump C, Zimmer S, et al
    Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma.
    PLoS One. 2022;17:e0269136.
    PubMed         Abstract available

  28. KOSKINEN A, Hemminki O, Forsti A, Hemminki K, et al
    Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.
    PLoS One. 2022;17:e0268922.
    PubMed         Abstract available


    Surgery

  29. FUJITA H, Motoyama S, An J, Nagakai Y, et al
    Peritumoral CD16b positive-neutrophil accumulation strongly correlates with regional lymph node metastasis in thoracic esophageal squamous cell cancer.
    Surgery. 2022;171:1535-1542.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: